This review systematically delineates the mechanisms by which depression facilitates cancer progression through neural and systemic inflammation—centered on key cytokines including IL - 6, TNF-α, and IL - 1β—and activation of multiple oncogenic signaling pathways, thereby establishing a robust mechanistic framework for depression–cancer comorbidity. The gene discussed is TNF; the disease is major depressive disorder.